首页> 中文期刊> 《现代诊断与治疗》 >辛伐他汀对维持性腹膜透析患者微炎症状态的影响

辛伐他汀对维持性腹膜透析患者微炎症状态的影响

             

摘要

Objective To explore the influence of Simvastatin on microninflammatory state in peri-toneal dialysis patients.Methods In 41 peritoneal dialysis patients and 20 healthy controls the level of high ̄sensitivity C ̄reactive protein (Hs ̄CRP), Interlukin ̄6 (IL ̄6), Tumor necrosis factor-a (TNF ̄a) and serum lipid level were determined,then the patients were randomly divded into 2 groups to receive simvastatin 20mg daily or nonlipid-lowering therapy.All above parameters were assayed again after 24 weeks.Results (1)Compared with healthy controls,the serum TG、Hs ̄CRP、IL ̄6、TNF ̄a were elevated significantly in peritoneal dialysis patients (P<0.01). (2)After 24 weeks'treatment,the level of TG,TC、Hs ̄CRP、IL ̄6 and TNF ̄a in simvastatin group were lower than be-fore,and the level of Hs ̄CRP、IL ̄6和TNF ̄a was much lower in simvastatin group than non ̄sim-vastatin group (P<0.05).Conclusion Simvastatin can relieve the microninflammatory state in peri-toneal dialysis patients.%目的:探讨辛伐他汀对维持性腹膜透析患者微炎症状态的影响。方法选择肾内科维持性腹膜透析患者41例,测定甘油三酯(TG)、总胆固醇(TC)、超敏C反应蛋白(Hs ̄CRP)、白细胞介素 ̄6(IL ̄6)和肿瘤坏死因子 ̄a(TNF ̄a)的水平,然后随机分为辛伐他汀治疗组(22例)和非辛伐他汀治疗组(19例)。治疗24w后检查TG、TC、Hs ̄CRP、IL ̄6和TNF ̄a。并设20例健康者作对照比较。结果(1)维持性腹膜透析患者TG、Hs ̄CRP、IL ̄6和TNF ̄a显著高于健康者(P<0.01);(2)治疗后24w,辛伐他汀治疗组TG、TC、Hs ̄CRP、IL ̄6和TNF ̄a的水平均有所下降,辛伐他汀治疗组Hs ̄CRP、IL ̄6和TNF ̄a下降的水平与治疗前及非辛伐他汀治疗组相比,差异具有显著性(P<0.05)。结论辛伐他汀能明显改善维持性腹膜透析患者的微炎症状态。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号